Jim Feldman on the Importance of Social Networking for Urologists

Video

Jim Feldman, chief innovative officer, Shift Happens, discusses change management for urologists and why it is important for them to have a social media presence.

Jim Feldman, chief innovative officer, Shift Happens, discusses change management for urologists and why it is important for them to have a social media presence.

Physicians have a tendency to be isolated from changes occurring worldwide, Feldman says, such as the prominence of social media. Because so many patients communicate via social networking sites such as Facebook, Twitter, and Yelp, physicians should not ignore its presence but rather become part of it.

Patients often refer physicians through these sites, but those referrals will be ignored if prospective patients are unable to locate the physician online and/or find any quality ratings on the practice. Ninety percent of referrals will lead to patients researching a physician online, he says.

The second challenge with social media is physicians also underestimate their patients' demographics. Though urologists typically have elderly patients, Feldman says this group has become more technological and social media savvy in order to communicate with their grandchildren, who are likely tapped into several social networks.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD